NZ Breast Cancer Research Review Issue 16

In this issue:

St Gallen 2013: Consensus on early breast cancer
Non-anthracycline regimen and TOP2A status
Adjuvant bevacizumab: no benefit in triplenegative breast cancer
Patient preference for subcutaneous trastuzumab
Chemoprevention agents for breast cancer risk reduction
Commentary on APBI with breast-conserving surgery

Please login below to download this issue (PDF)

Subscribe